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ABSTRACT
RNA polymerase (Pol) III synthesizes the tRNAs, the
5S ribosomal RNA and a small number of untrans-
lated RNAs. In vitro, it also transcribes short inter-
spersed nuclear elements (SINEs). We investigated
the distribution of Pol III and its associated tran-
scription factors on the genome of mouse embry-
onic stem cells using a highly specific tandem
ChIP-Seq method. Only a subset of the annotated
class III genes was bound and thus transcribed. A
few hundred SINEs were associated with the Pol III
transcription machinery. We observed that Pol III
and its transcription factors were present at 30
unannotated sites on the mouse genome, only one
of which was conserved in human. An RNA was
associated with >80% of these regions. More than
2200 regions bound by TFIIIC transcription factor
were devoid of Pol III. These sites were associated
with cohesins and often located close to CTCF-
binding sites, suggesting that TFIIIC might cooper-
ate with these factors to organize the chromatin. We
also investigated the genome-wide distribution of
the ubiquitous TFIIS variant, TCEA1. We found that,
as in Saccharomyces cerevisiae, TFIIS is associated
with class III genes and also with SINEs suggesting
that TFIIS is a Pol III transcription factor in
mammals.
INTRODUCTION
In eukaryotes, three nuclear RNA polymerases (Pol) are
responsible for the transcription of the genome. Pol I tran-
scribes a single RNA species, the precursor of the large
ribosomal RNAs (rRNA) and of the 5.8S rRNA. Pol II
transcribes all messenger RNAs and many non-coding
RNAs implicated in various processes ranging from
splicing, RNAs modiﬁcation (snoRNAs) or gene regula-
tion (miRNAs). Pol III transcribes the 5S rRNA, the
tRNAs and a small number of stable non-coding tran-
scripts (1,2). The U6 snRNA (mRNA splicing), RNAse
P RNA (tRNA maturation) and 7SL RNA (signal recog-
nition particle) are produced by Pol III in all eukaryotes
examined so far, whereas, the RNase MRP RNA (mito-
chondrial rRNA maturation) is transcribed by Pol II in
Saccharomyces cerevisiae and by Pol III in animals. Other
short Pol III products of rather poorly deﬁned functions,
such as the vault particle, the Y, 4.5S and BC1 RNAs are
largely speciﬁc to mammals (2). Finally, the short inter-
spersed repeated elements (SINEs) are retrotransposons
originating from class III (i.e. Pol III-transcribed) genes
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present in hundreds of thousands of copies in mammalian
genomes (3). SINEs can be transcribed by the Pol III tran-
scription machinery in vitro (4).
The promoters of class III genes are divided into three
categories depending on their organization and transcrip-
tion factor dependence (reviewed in refs 5,6; unless stated
otherwise, the nomenclature used for the class III machin-
ery subunits is that of the mammalian transcription system
according to ref. 5). Type II promoters of tRNA genes
harbor intragenic A and B boxes that are recognized by
TFIIIC, a six subunits factor (7 and references therein).
Once associated with DNA, TFIIIC positions a second
factor, called TFIIIB in yeast or TFIIIB-b in mammals
(8), upstream of the transcription start site (TSS). Yeast
TFIIIB and mammalian TFIIIB-b consist of the TATA
box-binding protein (TBP), BDP1 and BRF1, which are
related to TFIIB Pol II general transcription factor. Yeast
TFIIIB and mammalian TFIIIB-b recruit Pol III through
direct protein–protein interactions (9,10). The type I
promoter, unique to the 5S rRNA, is located within the
transcribed region and requires TFIIIA that acts as an
adapter for the binding of TFIIIC. The mammalian U6
promoter, a classical type III promoter, is located up-
stream of the transcribed region and consists of a
proximal sequence element (PSE) recognized by a
four-subunit factor variously called the PSE-binding
protein (PBP), the PSE transcription factor (PTF), or
the snRNA activating protein complex (SNAPc) (11–13),
and a TATA box which is bound by TFIIIB-a, in which
the BRF1 subunit of TFIIIB-b is replaced by BRF2
(8,14,15).
Since Pol III transcribes several rRNAs and the tRNAs,
it plays a central role in determining the translational
capacity of the cell (16). The regulation of Pol III tran-
scription plays a critical role in cell proliferation and
cancer (17). Indeed, artiﬁcially increasing tRNA and
5S rRNA transcription causes increased cell proliferation
and oncogenic transformation (18).
We discovered that TFIIS, a Pol II transcription elong-
ation (19) and initiation factor in S. cerevisiae (20,21), also
functions as a Pol III general transcription factor (22).
Indeed, TFIIS binding could be detected on all class III
genes and mutations that affected speciﬁcally Pol II or Pol
III transcription were identiﬁed. Biochemical study of
TFIIS role in Pol III transcription in yeast indicated
that it stimulates faithful transcription initiation in vitro.
In mouse, three isoforms of TFIIS, encoded by TCEA1,
2 and 3 exist (23–25). TCEA1 is expressed ubiquitous-
ly, contrary to TCEA2 and 3, which are expressed in
spermatocytes or in the liver and kidney, respectively.
Whether or not they are implicated in Pol III transcription
is presently not known.
RNAs synthesized by Pol III often originate from re-
peated genes, be it the repeated 5S gene or multiple copies
of some tRNA genes, raising the question whether all
copies of a gene are transcribed at a given time. In
addition, class III transcripts are difﬁcult to predict bio-
informatically. The nature of the class III transcriptome
was ﬁrst investigated in the yeast S. cerevisiae by analyzing
the genome-wide distribution of the Pol III transcription
machinery (26–28). The Pol III transcription machinery
was associated with nearly all tRNA genes irrespective
of their genomic localization, suggesting that they are
transcribed. Only one new class III transcript, snR52
snoRNA, was identiﬁed (26–28). The ChIP-Seq method
was very recently applied to the analysis of the Pol III
transcription machinery in various human cell lines allow-
ing a complete description of the class III transcriptome
(29–33). Unlike the situation in S. cerevisiae where all
tRNA genes are transcribed, only a subset of the tRNA
genes is bound by the Pol III machinery in human. The
identity of the bound tRNA genes varied from one cell
type to another. In addition, these studies allowed the
identiﬁcation of a few dozen new loci bound by Pol III.
In S. cerevisiae, TFIIIC was present, independently of
Pol III, on a small number of genomic locations, called
ETC loci for extra TFIIIC (26). These ETC loci are
conserved among yeast species suggesting that they
might have a functional role in chromatin organization.
Repressing artiﬁcially the expression of histones in vivo
leads to decreased nucleosome abundance. In such a situ-
ation, the expression of the ETC loci is induced (34). In
Schizosaccharomyces pombe, the presence of TFIIIC inde-
pendently of Pol III and TFIIIB marks several boundaries
between euchromatin and heterochromatin domains (35).
In S. pombe, TFIIIC plays an active role in delimiting the
boundaries since cis-acting mutations that abolish its
binding lead to the spreading of heterochromatic marks
in regions that are usually euchromatic and as a conse-
quence, lead to transcriptional silencing. Interestingly, a
large number of ETCs was also found in human cell lines
(1865 in K562 cells and 307 in HeLa cells; (30,31).
Moreover, the ETCs that were highly enriched for
TFIIIC were also often associated with CCCTC-binding
factor (CTCF) (31), a protein implicated in insulation and
chromosome looping and conformation (36), suggesting a
role for TFIIIC in deﬁning repressive domains in human.
In this study, we investigated the distribution of Pol III,
BRF1, BRF2, TFIIIC and one of the TFIIS homologs,
TCEA1, on the genome of mouse embryonic stem (ES)
cells using a highly speciﬁc ChIP-seq method that entailed
tagged ES cell lines. Our work provided a detailed analysis
of the active class III genes in mouse ES cells and led to
the discovery of new genes transcribed by this enzyme. We
found that only a few hundreds SINEs are transcribed by
Pol III. Interestingly, the presence of TCEA1 was detected
on the majority of the active class III genes suggesting that
it acts as a Pol III transcription factor in mammals. We
also took advantage of the genome-wide analysis of
TCEA1 to show that it is present at similar levels on
paused Pol II peaks of active and inactive genes suggesting
that it is not TFIIS recruitment that triggers the passage of
Pol II into elongation.
MATERIALS AND METHODS
Construction of the mouse ES cell lines
We used the recombineering technology (37) to generate
the targeting vectors that introduce the triple afﬁnity tag
in the subunits of Pol III, TFIIIB-a or -b, TFIIIC and
TFIIS. The 46C ES cell line (38) was transfected by
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electroporation with each targeting vector. Cells were
plated in D15 medium as described (39) and selected
with G418. Individual ES cell colonies were collected 7
days after electroporation, ampliﬁed and genotyped by
Southern blotting, in order to identify the clones that
underwent a homologous recombination event. In these
clones, a sequence encoding a 6 Histidine-Flag-HA tag,
followed by a neomycin resistance marker ﬂanked by
loxP sites, was inserted just after the last codon of the
gene encoding the protein to be tagged. For TCEA1, the
tag was inserted just after the start codon. The sequence of
the insertion cassette is given in the Supplementary Table
S2. The integration of the cassette at the right loci was
veriﬁed by Southern blotting using three or four different
restriction enzymes and DNA-polymerase chain reaction
(PCR). Transient transfection with a Cre recombinase ex-
pression vector was used to remove the selection cassette.
The karyotypes of all cell lines were veriﬁed. The genes
that were modiﬁed in the cell lines encoded RPC1
(MGI:2681836), RPC4 (MGI:1914315), BRF1
(MGI:1919558), BRF2 (MGI:1913903), TFIIIC220
(MGI:107887), TFIIIC110 (MGI:1919002), TFIIIC90
(MGI:2138937) and TCEA1 (MGI:1196624), respectively.
The expression of the tagged versions of the proteins was
veriﬁed by western blotting using HA7 anti-HA antibodies
(Sigma; Supplementary Figure S2).
ES cell lines culture
ES cells were cultured on embryonic ﬁbroblast feeder cells
blocked with mitomycin C in D15 medium [Dulbecco’s
Modiﬁed Eagle’s Medium High Glucose supplemented
with 15% fetal bovine serum, 2mM L-glutamine,
50U/ml penicillin, 50 mg/ml streptomycin, 0.1mM
non-essential amino acids (all from GIBCO), 0.1mM
2-mercaptoethanol (Sigma) and 1000U/ml LIF]. ES cells
were maintained at 37C, 5% carbon dioxide, fed with
fresh media daily, and transferred to new plates after
trypsinization.
Chromatin immunoprecipitation
Typically (150–200) 106 cells were collected for each
ChIP experiment. The cellular proteins and DNA were
cross-linked by the addition of formaldehyde (0.4% ﬁnal
concentration). The plates were incubated for 10min at
room temperature and then the reaction was stopped by
the addition of glycine (0.125M ﬁnal concentration). The
cells were washed twice with 10ml chilled phosphate
buffered saline (PBS). Each plate was scraped with 2ml
PBS with protease inhibitors (Roche complete, 10mM
PMSF dissolved in ethanol), pelleted by centrifugation
at 2500 rpm and resuspended in 1ml per dish of
FA/SDS buffer (50mM Tris–HCl pH 7.5, 150mM
NaCl, 1mM EDTA, 1% Triton X-100, 0.1%
Na-deoxycholate, 0.1% SDS) with protease inhibitors
and incubated on ice for 15min. The subsequent oper-
ations were performed at 4C. Chromatin was collected
by centrifugation for 20min at 12 000 rpm, resuspended in
the same amount of FA/SDS and put on a rotating wheel
for 1 h, centrifuged and resuspended in 0.4 volume of
FA/SDS with protease inhibitors. The 400 ml batches of
chromatin were fragmented with a sonicator (Diagenode)
to generate DNA fragments of 300–400 bp mean size. The
chromatin was collected by centrifugation at 14 000 rpm
for 10min and was kept at 80C until needed.
The immunoglobulin-coupled magnetic beads (Dynal)
used in the chromatin immunoprecipitation experiments
were prepared essentially as described previously (40).
Anti-HA antibody was HA7 H-3663 (Sigma) and
anti-Flag anti-body was F-1804 (Sigma). For each ChIP
experiment, 240 mg DNA (RPC1, RPC4, 46C) or 750 mg
DNA (BRF1, BRF2) of sonicated chromatin were
incubated with 150 ml beads for 2 h at room temperature.
The beads were magnetically pelleted and the supernatant
was removed. The beads were washed with 1ml of low salt
buffer (pH 8.0, 20mM Tris–HCl, 2mM EDTA, 150mM
NaCl, 1% Triton X-100, 0.1% SDS), then with the same
volume of high salt buffer (pH 8.0, 20mM Tris–HCl,
2mM EDTA, 500mM NaCl, 1% Triton X-100, 0.1%
SDS), then with low LiCl buffer (pH 8.0, 10mM Tris–
HCl, 1mM EDTA, 250mM LiCl, 1% NP-40, 1%
deoxycholate) and ﬁnally twice with TE buffer (pH 8.0,
10mM Tris–HCl, 1mM EDTA). The ﬁrst ChIP was per-
formed using the anti-HA antibody. The bound chromatin
was eluted using FA/SDS buffer containing the HA
peptide (0.5mg/ml; Ansynth Service) for 4 h at 16C
then overnight at 4C. For the second ChIP, the super-
natant was incubated with 50 ml beads coupled to
anti-Flag antibodies which were treated as above except
for the elution that was performed by incubation with a
buffer containing 1% SDS and 0.1 M NaHCO3. Reversal
of the cross-links and DNA puriﬁcation were performed
as described previously (41). TFIIIC subunits and TCEA1
ChIPs were fragmented using MNase I. The protocol will
be described in detail elsewhere (M. Ge´rard, manuscript in
preparation).
The immunoprecipitated DNA was analyzed by quan-
titative real time PCR on an ABI Prism 7000 or 7300
machine (Applied Biosystem; 40). Relative quantiﬁcation
using a standard curve method was performed and the
occupancy level for a speciﬁc fragment was deﬁned as
the ratio of immunoprecipitated DNA over total DNA.
Sequencing of the immunoprecipitated DNA and analysis
of the regions bound by the RNA pol III
For each chromatin immunoprecipitation, the DNA was
sequenced on a single Solexa genome analyzer GS or GA
IIx channel using the procedures recommended by the
manufacturer (Illumina). The characteristics of each
sequencing experiment are indicated in Supplementary
Table S3. The bound regions were identiﬁed using Quest
version 2.3 (42) and an in-house program that used Quest
method for peak calling. The data have been deposited to
the ArrayExpress database under accession number
E-MTAB-767.
RNA preparation
Total RNAs were isolated from 46C wild-type ES cells,
using 1ml of Trizol (Invitrogen) per 10 cm-dish, as
indicated by the manufacturer. Total RNAs were prepared
following the manufacturer’s protocol, except that the
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RNA pellet were washed with 80% ethanol, without shak-
ing. The RNAs were suspended in diethylpyrocarbonate
treated water, at around 2mg/ml and stored at 80C
until needed. Integrity of RNA was tested on 1.5%
agarose gel. Total RNA concentration and purity were
veriﬁed using a NanoDrop spectrophotometer ND-1000
(Thermo Scientiﬁc), measuring absorbance at OD 260/
280. Total RNA samples were treated with 1U of RQ1
DNase (Promega) per mg of RNA, for 1 h at 37C. DNase
was inactivated by the addition of 20mM ethylene glycol
tetraacetic acid, pH 8.0 (Stop solution) and heated at 65C
for 10min. The RNA was then precipitated with
isopropanol.
cDNA synthesis
cDNA synthesis was performed using SuperScript II
reverse transcriptase with random hexamer primers
(Invitrogen) according to the manufacturer’s instructions.
In brief, 5 mg of total RNA, 2 ml of random hexamer
primers (10mM), 1 ml of dNTP mix (5mM each) to 11 ml
in total, were incubated at 65C for 5min. After chilling
on ice for 2–3min and brief centrifugation, 5 ml of
ﬁrst-strand synthesis buffer (5, containing 250mM
Tris–HCl [pH 8.3], 375mM KCl, 15mM MgCl2), 2 ml of
0.1M DTT, were added and the tubes were incubated at
25C for 1min. Then, 1 ml of (200U/ml) of SuperScript II
reverse transcriptase was added and the reaction was ﬁrst
incubated at 25C for 10min, followed by incubation at
42C for 1 h. Reverse transcriptase activity was terminated
by incubation at 70C for 15min. 1 ml RNase H
(Invitrogen, 2U/ml) was added and further incubated at
37C for 20min. Samples were stored at 20C until
needed. The cDNA solution was diluted 10-fold before use
in reverse transcriptase-PCR (RT–PCR). PCR were per-
formed using speciﬁc primers covering the region of
interest. The reactions contained 25 ng of cDNA, and
primers at a ﬁnal concentration of 150 nM. RT-PCR re-
actions were analyzed by gel electrophoresis. Further,
total RNA samples were analyzed for the possible
presence of DNA contamination by PCR using RNA
not reverse-transcribed.
RESULTS
Setting up a high-speciﬁcity tandem afﬁnity chromatin
immunoprecipitation method in mouse ES cells
To identify the regions bound by the Pol III transcription
machinery, we developed a tandem afﬁnity chromatin
immunoprecipitation method in mouse ES cells. Two dif-
ferent speciﬁc subunits of Pol III, RPC1 and RPC4, the
BRF1 and BRF2 subunits of TFIIIB-b or TFIIIB-a, re-
spectively and the TFIIIC220, TFIIIC110 and TFIIIC90
subunits of TFIIIC were tagged (Supplementary
Table S1). To investigate whether or not TFIIS is a Pol
III transcription factor, TCEA1 was also tagged. We
introduced a cassette encoding consecutively six histidines,
one Flag and one HA epitope just after the last sense
codon of the Pol III, BRF and TFIIIC genes. A
neomycin marker ﬂanked by loxP sites follows the tag
cassette. The construction was introduced in 46C mouse
ES cell genome using the recombineering method
(Supplementary Figure S1 and Supplementary Table S2)
(37). The neomycin marker was removed by expressing the
cre recombinase. The correct integration of the cassette at
the endogenous locus and the excision of the neomycin
marker were veriﬁed by Southern blotting and PCR.
The expression and correct size of the C-terminally
tagged proteins were veriﬁed by western blotting with
a monoclonal anti-HA antibody (Supplementary
Figure S2).
Chromatin from the RPC1-, RPC4-, BRF1- or BRF2-
tagged ES cell lines was prepared. ChIP experiments in
RPC1 or RPC4 ES lines with anti-HA antibodies
enriched strongly a tRNA-val gene and the H1 gene
(from 40- to 110-fold) but not the ARBP gene, which is
transcribed by Pol II (Figure 1A). We then tested whether
genes that depend on BRF1 or BRF2 could be distin-
guished. BRF1 ChIP enriched speciﬁcally two tRNA
genes. Conversely, BRF2, but not BRF1, was associated
with H1 gene, encoding the RNA subunit of the RNase P,
and U6 (Figure 1B) (5,6).
To improve the speciﬁcity of the ChIP experiments,
tandem immunoprecipitations were performed. The chro-
matin was ﬁrst ChIPed with the anti-HA antibody as
above, and then eluted by competition with an HA
peptide. The enriched chromatin was submitted to a
second round of ChIP with a monoclonal anti-Flag
antibody. The second ChIP further improved the enrich-
ment ratio above background up to 8-fold depending on
the protein and gene considered (Figure 1C and
Supplementary Figure S3). The protocol used here is
thus, highly speciﬁc for ChIP experiments of tagged
proteins expressed from their native locus in mouse ES
cells. It is also generic since it does not depend on the
generation of high speciﬁcity antibodies.
Analysis of the regions bound by RNA polymerase III
DNA from the chromatin associated with Pol III was
sequenced using a Solexa Genome Analyzer. The com-
parison of ChIP-Seq experiments using tagged RPC1
and RPC4 ES cell lines allowed us to cross-validate the
Pol III-binding sites. We considered as bound regions,
only those that showed co-occupancy by RPC1 and
RPC4. These regions were validated if the number of
tags mapping within the deﬁned interval in the ChIP-Seq
experiments with RPC1 and RPC4 were both 5-fold
higher than in the untagged ES cell line, which was used
as a negative control. Regions that satisﬁed only one of
the two conditions were visually inspected using the
UCSC genome browser and rejected if the 46C track
showed a high background around the bound region.
The protein-bound regions were annotated using the
mm9 UCSC mouse database. The regions that were
associated with more than one annotation were visually
inspected and eventually split to associate one region with
each annotation. If one annotation was associated with
two or more regions, these were inspected and eventually
fused. Figure 2 and Supplementary Figure S4 show
examples of tag density proﬁles on various regions repre-
sentative of several class III genes. Data concerning the
bound regions can be found in Supplementary Table S4.
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tRNAs. A total of 284 tRNA genes were bound by Pol
III, including one selenocysteine tRNA gene and one pos-
sible suppressor. Of these, 271 were predicted by Coughlin
et al. (43) and 281 by the Genomic tRNA Database
(GtRNADb). Coughlin et al. predict that 461 tRNA
genes exist based on the sequence of the expressed
tRNAs. GtRNADb, which relies upon the
tRNAscan-SE program (44), predicts the existence of
433 tRNA genes (including two selenocysteine tRNAs
and one possible suppressor) in the mouse genome.
Altogether, 526 tRNAs are annotated on the mouse
genome by these two databases. Totally, 59 and 65% of
the genes predicted by Coughlin et al. and GtRNADb,
respectively, were bound by Pol III in mouse ES cells.
This observation raised the possibility that some tRNAs
were not detected because they cannot be identiﬁed by
unique tags. The percentage of nucleotides that could
not be mapped (NM score) within 150 nt on either side
or within the tRNA genes that were actually bound by Pol
III was computed. For each tRNA, we considered the
lowest NM score from the three regions. We found that
the worst NM score for a bound tRNA was 75%. We
ﬁgured out that among the 242 tRNA genes predicted
by Coughlin et al. or GtRNAdb that were not bound by
Pol III, only 14 had an NM score >75%. Hence, we did
not underestimate the number of bound tRNA genes by
>13.2%. We performed independent ChIP experiments
for three bound tRNA genes and two mappable
unbound tRNA genes, which agreed with the ChIP-Seq
experiments (Supplementary Figure S5). The genomic dis-
tribution of bound tRNA genes and other class III genes is
shown in Supplementary Figure S6.
snRNAs. In addition to tRNA genes, we also found bind-
ing of Pol III transcription machinery on the U6, 5S, 7SK,
7SL, 4.5S, BC1, HY1 and HY3 genes. However, the num-
ber of bound genes was very small compared to that pre-
dicted in Repbase (Table 1). For example, Repbase
predicts 1269 U6 genes and Ensembl, 617 when we actually
found only 5 that were bound. As for the tRNA genes, we
performed an independent ChIP experiment and veriﬁed
for two genes of each 7SL, 7SK, U6 and HY3, one bound
in the ChIP-Seq experiment and one mappable but
unbound, that Pol III was present or not as expected
(Supplementary Figure S5).
New Pol III transcripts. About 30 regions were bound by
both RPC1 and RPC4, but were not annotated as Pol
III-transcribed genes or SINEs and could thus correspond
to new Pol III transcripts. Of note, these regions were
neither annotated as transcribed by Pol II, nor corres-
ponded to miRNAs. We veriﬁed by an independent
ChIP experiment for nine of those regions that they
were indeed bound by RPC1 and RPC4 (Supplementary
Figure S7A). Furthermore, we looked for the presence of
an RNA associated with the Pol III-bound region by RT–
PCR (Supplementary Figure S7B). An RNA was tran-
scribed from 16 regions out of the 18 that were examined.
Most of these regions were conserved in the rat genome but
only one was highly conserved in human (Supplementary
Figure S7C and Supplementary Table S5). The latter
region, which was also associated with Pol III in human,
had a typical organization for class III genes with
conserved A-box and B-box and terminator. Altogether,
these results strongly suggest that we have identiﬁed new
class III transcripts.
Figure 1. Chromatin immunoprecipitation of the Pol III transcription
machinery in mouse ES cell lines. ChIP experiments were performed
with the HA7 H-3663 anti-HA antibody (A and B) as described in
‘Materials and Methods’ section. (A) Chromatin extracts from RPC1
or RPC4 cell lines were used to show Pol III enrichment on different
types of class III genes but not on the ARBP class II gene. (B) Extracts
from BRF1 or BRF2 cell lines were used to demonstrate speciﬁc en-
richment of TFIIIB-b or TFIIIB-a on genes with type 2 (tRNAs) or
type 3 promoters (H1, U6), respectively. An untagged cell line was used
as a negative control. (C) Tandem ChIPs improved signal to noise
ratios. Single round ChIP (RPC4 single IP) were performed as above
with HA7 H-3663 anti-HA antibody and were compared with experi-
ments in which a second round (RPC4 tandem IP) of immunopre-
cipitation was done with F-1804 anti-Flag antibody after elution of
proteins with an HA peptide. Enrichment-folds of sequences from an
RPC4 ES cell line chromatin extract relative to an untagged cell line
chromatin are indicated.
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Distribution of BRF1 and BRF2 on class III genes
We also tagged the BRF1 or BRF2 subunits of TFIIIB-b
or TFIIIB-a, respectively, to investigate which genes
depend on either form of the Pol III factor. Type I and
II promoters require the presence of BRF1 in TFIIIB-b
transcription factor for their transcription while type III
uses BRF2 as a subunit of TFIIIB-a. As expected, BRF1
was exclusively associated with types I and II promoters
(Figures 2A and 3A–C), whereas, BRF2 was bound to
type III promoters only (Figure 3D and Supplementary
Figure S4), indicating that no class III gene could use both
TFIIIB variant. BRF2 was associated with a small
number of snRNAs that included U6, 7SK, the H1 and
MRP RNA genes, U6atac, the tRNAsec and two of the Y
RNA genes, HY1 and HY3. Apart from these genes that
were already predicted to depend on BRF2, no new region
was found. The new genes were associated with low, or
sometimes background levels of BRF1 (Figure 3E). This
situation probably stems from the fact that the number
of tags associated with the new genes is often low even
for the Pol III ChIP. The number of tags associated with
class III genes in experiments with the BRF1 cell line
is around 10-fold smaller than with the RPC4 cell line
(Supplementary Table S4, compare RPC4.SUM_
DENSITY to BRF1.SUM_DENSITY). A thorough as-
sessment of BRF1 and/or BRF2 presence on the new
genes would thus require a 10-fold deeper sequencing.
We wondered where the two forms of TFIIIB were pos-
itioned, relative to the mature RNA 50-end (the TSS of
mouse class III genes have not been systematically
determined). On tRNA genes, BRF1 peak density was
located 10 nt upstream of RNA 50-ends (Figure 3A),
which is within a few nucleotides of the position deter-
mined by in vitro footprinting experiments. A similar situ-
ation was found for BRF2 on genes with type III
promoters with a peak of tag density located 14 nt
PB1D7
tRNA_Cys_TGY tRNA_Cys_TGY
1 kb
97848500 97850000
RPC1
RPC4
BRF1
BRF2
Untagged
Repeat-Masker Element
B1_F1LTR
RPC1
RPC4
Untagged
Repeat-Masker Element
BRF2
BRF1
1 kb
96245500 96246500
BA
Figure 2. Representative examples of sequence reads that map on bound regions. (A) Binding of Pol III and BRF1 to two tRNA genes and a SINE.
The sequences that map to chromosome 11 are displayed using the UCSC genome browser. A 1kb scale is shown at the top of the Figure. The
sequence tags are represented by colored rectangles. Tags identiﬁed in the ChIP-Seq experiments performed with the RPC1-tagged, RPC4-tagged,
BRF1-tagged or BRF2-tagged ES cell lines and 46C negative control cell line are colored in blue, yellow, red, green and gray, respectively. Light
colors indicate the sequences that match the top strand. Dark colors indicate the tags that match the bottom strand. The location of repeated
sequences, according to RepBase, is indicated at the bottom of the Figure by gray or black boxes. The two black boxes refer to two tRNA-Cys-TGY
genes. The bound SINE is a PB1D7 repeat of the Alu family. (B) Binding of Pol III transcription machinery to an unannotated region on
chromosome 3.
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upstream RNA 50-ends (Figure 3D). Using data from
Kagey et al. (45), we also looked at the distribution of
TBP relative to the class III genes. TBP was positioned
17 or 12 nt upstream of RNA 50-ends for class II or class
III promoters, respectively.
Transcription of SINEs
Pol III in vitro transcription systems can drive the tran-
scription of SINEs (4). We wondered whether some of the
SINEs could be bound by Pol III, and thus most probably
be transcribed in vivo. Indeed, we found 241 locations on
the mouse genome that were associated with both RPC1
and RPC4 and had a SINE annotation according to
Repeatmasker. We ﬁrst looked at the distribution of the
sequence divergence of the SINEs (Supplementary Figure
S8A). The distribution is bi-modal with maxima at 7 and
27% divergence and a minimum at 13%. The SINEs were
separated in two classes according to their divergence
using 13% as threshold. Notably, most (80%) of the
bound SINEs belonged to the highly conserved category
(Supplementary Figure S8B).
We wondered if the small number of observed bound
SINEs in our ChIP-Seq experiments could stem from the
low mappability of the regions encompassing the SINEs.
To answer this question, we used an approach that was
similar to the one applied to the tRNA genes. The bound
SINEs were divided in two populations depending on
whether their divergence was 13%. We determined the
lowest NM score for bound SINEs of each category. The
A
C D E
B
Figure 3. Distribution of Pol III, TBP, BRF1 and BRF2 relative to class III genes. Tag densities are shown for RPC1, RPC4, BRF1, BRF2 and
TBP (45) relative to the location of the RNA 50-end for (A) tRNA genes, (B) unbound tRNA genes, (C) SINEs, (D) BRF2-associated genes and (E)
new class III genes. For these, neither the transcription orientation, nor the TSS or end is known. Hence, the distribution is shown relative to the
RPC4 density peak.
Table 1. Pol III-associated regions
RNA Number
bound
Number
predicteda
Percent
bound
tRNA 284 526 53.8
4.5S 13 1475 0.81
5S 3 984 0.30
7SK 1 665 0.15
7SL 2 276 0.72
BC1 2 6351 0.03
HY1 1 37 2.70
HY3 1 15 6.67
HY4 0 2 0.00
HY5 0 1 0.00
U6 5 1269 0.39
aThe number of predicted class III transcripts are extracted from
GtRNAdb and Coughlin et al. (43) for the tRNAs and from
Repbase for the other ones.
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worst NM score within the SINE or the 150 nt ﬂanking-
regions was 65% for the conserved category and 50% for
the diverged category. We then computed the NM score
for all the SINEs predicted by Repeatmasker for each of
the two divergence classes and determined the number of
SINEs present in the mouse genome that had their two
ﬂanking regions with NM scores above those observed in
bound SINEs. We postulated that the proportion of
bound SINEs in the non-mappable population was similar
to that in the mappable population. We could thus esti-
mate that only around 10 non-mappable SINEs might be
bound.
We searched in the bound SINEs for the presence of the
TRGYTYARTGG and GTTCRAWTC sequences, which
correspond to the A- and B-boxes in human (30). Of them,
64% contained an A-box and 87% a B-box (at P-value
103), indicating that most of them had highly conserved
type II promoters. Pol III-associated SINEs were found
throughout the mouse genome and were not particularly
associated with other categories of class III genes
(Supplementary Figure S6B). Altogether, these observa-
tions indicate that a limited set of the SINEs direct Pol
III transcription in vivo.
Chromatin environment of class III genes
We looked for the presence of various chromatin marks
around the bound and unbound class III genes, com-
paring the distribution of H3K4me1, -me2, -me3, which
are considered as active chromatin marks, and
H3K27me3, that is an inactive chromatin mark (46–48).
We also analyzed the distribution of H3K9me3, which are
deposited at many euchromatic loci in mouse ES cells (49).
Interestingly, both Pol III bound tRNA genes and BRF2-
dependent genes were surrounded by peaks of H3K4me3
located around 400 nt on either side of the RNA 50-ends
(Supplementary Figure S9). H3K4me3 mark was absent
from unbound tRNA genes (data not shown). The euchro-
matic mark H3K9me3 might be slightly enriched on either
side of active class III genes. On the contrary, H3K27me3,
which is typically heterochromatic was completely absent.
This pattern is extremely similar to that of Pol
II-transcribed genes.
Distribution of TFIIIC
TFIIIC is required for the transcription of class III genes
that are under the control of types I and II promoters, i.e.
5S and tRNA genes. However, in S. pombe, S. cerevisiae
and human, TFIIIC binds some regions independently of
Pol III (26,30,31,35). We explored the genome-wide distri-
bution of TFIIIC in mouse ES cell lines where one subunit
of TFIIIC, TFIIIC220, 110 or 90, was tagged. Since
the standard ChIP protocol that used sonication for DNA
shearing did not give satisfactory results, it was modiﬁed
by the inclusion of a MNase I DNA digestion step (M.G.,
manuscript in preparation). Tandem ChIP experiments
allowed the identiﬁcation of 2652 regions that were con-
sidered as bound since they were consistently enriched in
ChIP experiments with the three TFIIIC-tagged cell lines
but not in an untagged control cell line (Supplementary
Table S6).
Of the 283 tRNA genes bound by Pol III (excluding the
selenocysteine tRNA which has a type III promoter), 261
were also associated with signiﬁcant levels of all three
TFIIIC subunits. The three subunits displayed similar dis-
tributions downstream of BRF1 on the body of the tRNA
genes (Figure 4A). The distribution of the tags on tRNA
genes was very similar for the three subunits tested,
showing an extended association with tRNA genes.
TFIIIC was absent from the tRNA genes that were not
bound by Pol III or BRF1 (data not shown). In line with
their promoter organization, Pol III-bound SINEs were
also associated with TFIIIC and BRF1, but not BRF2
(Figure 4B). As expected from previous in vitro experiments
(5), the BRF2-associated genes were completely devoid of
TFIIIC (Figure 4C). Interestingly, the three TFIIIC
subunits were generally associated with the new class III
genes while no BRF2 could be found suggesting that they
depend on TFIIIC for their transcription (Figure 4D).
Several recent studies pointed at the presence in human
cell lines of numerous ETC loci where TFIIIC is present
but devoid of Pol III or TFIIIB-a or -b (26,30,31,35).
Similarly, 2233 ETC loci bound by the three TFIIIC
subunits were detected by our ChIP-Seq experiments.
TFIIIC has been shown to play a role in the organization
of chromatin in S. cerevisiae and S. pombe and to act as a
barrier in the extension of heterochromatin into euchro-
matic territories (35,50,51). It has been shown that
CTCF protein plays a similar insulator role in mammals
(36). Moreover, CTCF interacts with cohesins to position
it at many sites (52). A correlation between CTCF and
ETC sites in human cells has been found (30,31). To in-
vestigate the potential correlation between the ETCs- and
CTCF-binding sites in mouse ES cells, the ETCs were
ordered according to their distance relative to the
CTCF-binding sites (data taken from ref. 53). In
parallel, an identical number of randomly selected regions
were ordered using the CTCF-binding site distance criter-
ion. Heat maps of the tag density for TFIIIC220 and
CTCF were generated (Figure 5A) and compared
with the heat maps of the randomly selected regions
(Figure 5B). In agreement with the observations made in
human cells, we found that 85% of ETCs also had
CTCF-binding sites within 20 kb (Figure 5A). The distri-
bution of CTCF was clearly different when regions were
selected randomly (Figure 5B; compare the sigmoid curves
in the two panels). The CTCF-binding sites were previous-
ly shown to be associated with the Smc1A and Smc3
subunits of cohesin (45). Heat maps were drawn for
Smc1 and Smc3 and conﬁrmed the clear co-occupancy of
these proteins with CTCF. Intriguingly, in addition to
being closely associated with CTCF, we observed that
Smc1A and, to a lesser extent, Smc3 were enriched at the
ETCs themselves, as indicated by the increased tag density
centered on the ETCs (Figure 5A) which is absent from the
maps of the randomly selected regions (Figure 5B).
Enrichment of TCEA1 isoform of TFIIS at class II and
class III genes
TFIIS is a transcription elongation factor that stimulates
Pol II transcription elongation and initiation. Moreover,
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we have shown that it acts positively on Pol III transcrip-
tion in S. cerevisiae (22). The distribution of TFIIS on the
genome of mouse ES cells was thus investigated. Three
variants of TFIIS are encoded by the mouse genome.
The ubiquitously expressed variant TCEA1 was tagged
at its N-terminus because C-terminal tagging abolishes
TFIIS function in yeast. Chromatin immunoprecipitation
was performed using the same protocol that was used for
TFIIIC.
We found that 57.6% of the tRNA genes and 50% of
the BRF2-dependent genes that were associated with
Pol III were also bound by TCEA1 (Figure 6 and
Supplementary Figure S10) using a 3-fold signal to back-
ground threshold. About 41.1% of the bound SINEs and
16.7% of the new class-III genes were also bound by
TCEA1 using the same criterion. We wondered if the pres-
ence of TCEA1 on class III genes does require Pol II (data
from ref. 54). On tRNA genes and active SINEs, only very
low levels of hypophosphorylated Pol II is found upstream
of the genes (Figure 6A and B). Low levels of
hypophosphorylated Pol II was also present downstream
of the SINEs. Pol II phosphorylated on serine 2, 5 or 7 of
the CTD was not signiﬁcantly enriched on the regions
surrounding active tRNA genes or SINEs. The distribu-
tion of TCEA1 on tRNAs and SINEs resembled that of
Pol III but was shifted upstream toward the 50-end in line
with its possible role in transcription initiation by Pol III
(22). Intriguingly, the hypophosphorylated, S7P and S5P
forms of Pol II were all signiﬁcantly present upstream of
BRF2-associated genes (Figure 6C). The level of unphos-
phorylated Pol II was around 5-fold more abundant on
BRF2-associated genes, than on active tRNA genes.
However, two peaks of TCEA1 were found on BRF2-
dependent genes, one associated with Pol II, the other
with Pol III. These observations suggest that TFIIS
plays a role in Pol III transcription.
The distribution of TCEA1 on class II genes was also
analyzed. When ordered according to RNA steady-state
levels transcribed from a given gene (measured by
RNA-seq; C. Keime and M. Ge´rard, manuscript in
BA
DC
Figure 4. Distribution of TFIIIC relative to class III genes. Tag densities are shown for TFIIIC220, 110, 90, BRF1 and BRF2 relative to the
location of the RNA 50-end for (A) tRNA, (B) SINEs, (C) BRF2-associated. For the new class III genes (D) the distribution is shown relative to the
RPC4 density peak.
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preparation), Pol II and TCEA1 distributions were similar
(Figure 7). Indeed for the 10 000 most highly expressed
genes, the Spearman correlation coefﬁcient between Pol
II and TCEA1 occupancies on class II genes was 0.77. A
large fraction of the genes, active or inactive, have paused
Pol II just after the TSS. We wondered if TCEA1 occu-
pancy might correlate with the transition from pausing to
elongation. This is not the case since the levels of Pol II
and TCEA1 on the pausing regions (deﬁned here as the
300 bp after the TSS) of actively transcribed or
non-productive genes with paused Pol II were similar,
with Spearman correlation coefﬁcient of 0.59 and 0.54,
respectively (see Figure 7B and C for examples of Pol II
and TCEA1 distributions). The Spearman correlation co-
efﬁcient between TCEA1 and Pol II occupancies down-
stream of the pausing region were 0.75 and 0.76,
respectively, for the two classes of genes.
DISCUSSION
The genome-wide distribution of Pol III, TFIIIB-b, its
variant form TFIIIB-a and TFIIIC has been established
BA
-20 0 +20
kb
C220 CTCF Smc1a Smc3 C220 CTCF Smc1a Smc3
Figure 5. Distribution of CTCF, Smc1a, Smc3 relative to ETC-bound TFIIIC220. (A) Distribution of CTFC, Smc1a and Smc3, relative to
TFIIIC220. The ETC regions bound by TFIIIC220 (C220) were ordered relative to their distance to CTFC-binding sites using seqMINER (63).
The windows span 20 kb upstream and downstream the center of TFIIIC bound regions. The distribution of Smc1a and Smc3 on the same regions is
shown on the two right panels according to the same order. (B) Distribution of CTCF, Smc1a and Smc3 relative to randomly selected regions.
Randomly selected regions were sorted according to the distance of CTCF-binding site to the center of the region. Smc1a- and Smc3-binding sites are
shown according to the same in the two right panels.
CBA
Figure 6. Distribution of TCEA1 and Pol II relative to class III genes. Tag densities for RPC4, TCEA1 (this work) and the hypophosphorylated
(RNAPII) (64), serine 2 (RNAPII_S2P) (54), serine 5 (RNAPII_S5P) and serine 7 (RNAPII_S7P) phosphorylated forms of Pol II, are shown relative
to the location of the RNA 50-end for bound (A) tRNA, (B) SINEs and (C) BRF2-associated genes. The tag density scale for RPC4 is indicated on
the right side of the plots.
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in mouse ES cells using a highly speciﬁc ChIP-Seq proced-
ure. Only 284 tRNA genes out of 526 predicted genes were
indeed associated with Pol III and, hence, were likely to be
transcribed. The fact that Pol III was found only on a very
small number of SINEs suggests that mechanisms exist to
prevent their transcription. Additionally, 30 sites on the
mouse genome were associated with Pol III, but lacked
any annotation, most of them being transcribed. The
regions encoding the new transcripts were usually
conserved in the rat genome but except in one case, this
conservation did not extend to man. The chromatin envir-
onment of class III genes resembles strongly that of class
II genes with high levels of H3K4me3 upstream and
downstream of the gene and low levels around the tran-
scription start site. Studies in human have indicated that
Pol II is associated with class III transcription (29,30,32).
However, we found different situations depending on
whether we looked at BRF1- or BRF2-associated genes.
Upstream of tRNA genes, only very low levels of
hypophosphorylated Pol II were observed. On the
contrary, Pol II was present upstream of BRF2-
associated genes. Finally, we observed that TCEA1
isoform of TFIIS was associated with classes II and III
genes. The distribution pattern of TCEA1 suggests that it
A
B
C
Figure 7. Distribution of TCEA1 on class II genes. (A) Hypophosphorylated Pol II (RNAPII) and TCEA1 have similar distribution on genes. The
distribution of Pol II, S5P Pol II and TCEA1 5 kb upstream and downstream of the TSS is plotted for the 10 000 most expressed genes in ES cells
based on RNA-Seq (M.G., manuscript in preparation). The genes were ordered according to their expression levels using seqMINER. (B) Examples
of Pol II and TCEA1 proﬁles on highly transcribed genes. TTS: Transcription termination site. (C) Examples of Pol II and TCEA1 proﬁles on
paused unproductive genes.
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is not sufﬁcient to stimulate the transition of paused Pol II
into elongation. Moreover, it indicates that TFIIS could,
as in yeast, be a Pol III general transcription factor.
Thanks to our highly speciﬁc tandem ChIP-Seq
protocol and cross-validation by experiments that
investigated independently the distribution of several
subunits belonging to Pol III or TFIIIC, the mouse Pol
III transcriptome is now precisely deﬁned. As in human
cell lines (29–33), the Pol III transcription machinery is
associated with only a subset of the tRNA genes. This
situation also holds true for the BRF2-associated genes.
We estimated that <5% of the tRNA genes might have
escaped our analysis. A total of 30 unannotated regions
were associated with signiﬁcant levels of Pol III. Several
arguments indicate that they are indeed transcribed by Pol
III. First, we could verify the presence of Pol III in inde-
pendent experiments. Second, in addition to Pol III, most
of these regions were associated with TBP and TFIIIC. In
contrast, BRF2 was present only on regions that were
already known to require TFIIIB-a for their transcription
in vitro. Third, an RNA was found in >80% of the new
regions that we tested. Finally, none of these regions was
annotated. Experiments have suggested that a small
number of miRNAs is transcribed by Pol III in human
(55,56). This view was later challenged by other experi-
ments (57). In mouse ES cells, none of the newly identiﬁed
regions overlapped with miRNA annotations suggesting
that the transcription of this class of RNA by Pol III is
very limited. The function, if any, of the RNA transcribed
from the new Pol III-associated regions will await further
studies.
In vitro transcription experiments have demonstrated
that Pol III is able to transcribe the SINEs (4). It is also
known that SINEs, which number in hundreds of thou-
sands in mammalian genomes, result from the insertion of
retrotranscribed Pol III transcripts (3). We thus wondered
if we could estimate how many of them are indeed
associated with the Pol III transcription machinery.
Unexpectedly, only 241 SINEs were bound, usually at
rather low levels compared with tRNAs. The transcribed
SINEs were distributed throughout the genome independ-
ently of tRNA or other class III genes. The small number
of transcribed SINEs suggests that a general mechanism
might repress their expression. This situation might,
however, be speciﬁc to ES cells.
In human cells, class II genes are closely associated with
class III genes. Pol II transcribed genes are often present
upstream of class III genes (29–32). Even though Pol II
transcription inhibition has only a modest effect on the
transcription of adjacent class III genes, it has been
argued that Pol II might regulate Pol III transcription
(32). Our observations in mouse indicated that, at
actively transcribed tRNA genes, the level of Pol II is ex-
tremely low. Moreover, while the hypophosphorylated
non-elongating form of Pol II was present upstream of
the bound tRNA genes at very low levels, the other
forms were virtually absent. In contrast, hypophosphory-
lated, S7P and S5P Pol II were all present upstream of
BRF2-associated genes. This observation suggests that,
in mouse, the chromatin organization around transcribed
tRNA genes, allows low levels of hypophosphorylated Pol
II to bind but prevents the transition to elongation. On the
other hand, the promoters of BRF2-associated genes,
which are gene external and resemble those of Pol II
transcribed genes, would allow the association of class II
transcription machinery and divergent transcription
relative to Pol III. The observation of different behaviors
for tRNA genes and BRF2-associated genes strongly
suggests that, on tRNA genes, Pol II presence has
probably limited functional signiﬁcance in mouse. Type
III promoters are gene external and their transcription
by Pol III is determined by the presence of a TATA box
which, if absent, leads to transcription by Pol II (58,59). It
has also been shown that U6 transcription is decreased
2-fold in human cell lines when Pol II transcription is
inhibited (60). It is thus possible that, as in human, the
presence of Pol II upstream of BRF2-associated genes in
mouse might stimulate their transcription by Pol III.
The binding pattern of TFIIIC was clearly distinct from
that of Pol III. Whereas the factor was present on tRNA
genes and on the new Pol III-associated regions, more
than 2200 TFIIIC-binding sites were located far away
from class III genes. This number is similar to that of
the ETC loci in K562 human cells where 1865 such sites
were found (31). The ETC sites have ﬁrst been detected in
S. cerevisiae and S. pombe and have been shown to play a
role in the organization of chromatin (26,35,51). Even
though the ChIP-Seq experiments were performed with
different protocols, antibodies and in different cell lines,
the ETC site number in human is remarkably similar to
that found in mouse, both organisms having comparably
sized genomes (3.1 Gb and 2.9 Gb for man and mouse,
respectively). CTCF has been shown to have an
enhancer-blocking activity (36). In mouse ES cell lines,
CTCF is loosely associated with ETC loci, a relationship
that might be indicative of an interdependence and/or
common role in silencing transcription of adjacent se-
quences. Cohesins are required for the localization of
CTCF at boundary elements (52). In line with previous
observations, in mouse and human, Smc1a and Smc3 dis-
tributions closely follow that of CTCF. Remarkably,
Smc1a and Smc3 were also present on the TFIIIC peak.
In S. cerevisiae mutations in Smc1 or Smc3 affects the
boundary function of tRNA genes (35,50,51). Moreover,
a recent report has shown that cohesins connect enhancers
and promoters through DNA loops via interactions with
the Mediator, stimulating Pol II transcription (45). These
observations raise the intriguing possibility that the
presence of cohesins at ETCs and CTFC-binding sites
might stimulate the formation of DNA loops, promoting
an enhancer-blocking activity of TFIIIC and shape the
organization of chromatin.
In S. cerevisiae, we showed that TFIIS occupies nearly
all class III genes. In addition, some TFIIS mutations spe-
ciﬁcally affect Pol II or Pol III transcription in vitro and
in vivo demonstrating that TFIIS plays a key role in Pol III
transcription in yeast (22). The observation that, in mouse
ES cells, TCEA1 is associated with the majority of class
III genes independently of Pol II, strongly suggests that
TFIIS is also a Pol III transcription factor in mammals.
Intriguingly, its distribution on class III genes is skewed
toward the TSS when compared to that of Pol III, in line
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with a putative role in transcription initiation as we
proposed in yeast.
Previous studies in Drosophila have shown that TFIIS
plays a role in stimulating paused Pol II to enter active
elongation (61,62), a situation that could also hold in
mouse ES cells. We wondered if the presence or absence
of TFIIS could be related to pausing on class II genes.
TFIIS occupancy on class II genes followed that of Pol
II both on elongating genes and on non-productive genes
that have high levels of paused Pol II, indicating that the
pause is not the consequence of the absence of TFIIS. Our
observations thus raise the intriguing possibility that
TFIIS activity, but not its recruitment, might be somehow
stimulated upon the entry into elongation.
In summary, this study provides a high-resolution map
of class III genes active in mouse ES cells and it shows that
the TFIIIC transcription factor is present at around 2000
sites on the genome independently of Pol III and its other
factors TFIIIB-a or -b, possibly playing a role in chroma-
tin organization. Finally, we provide evidence that
support a role for TFIIS Pol II elongation factor in class
III transcription.
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